About the Authors

Gilles Riveau

gilles.riveau@gmail.com

Affiliation Inserm – Université Lille 2, Institut Pasteur de Lille, Lille, France

Dominique Deplanque

Affiliations Inserm CIC-CRB 9301, CHRU, Lille, France, Université Lille – Nord de France, Département de Pharmacologie Médicale, Faculté de Médecine, Lille, France

Franck Remoué

Affiliation Inserm – Université Lille 2, Institut Pasteur de Lille, Lille, France

Anne-Marie Schacht

Affiliation Inserm – Université Lille 2, Institut Pasteur de Lille, Lille, France

Hubert Vodougnon

Affiliation Inserm CIC-CRB 9301, CHRU, Lille, France

Monique Capron

Affiliation Inserm – Université Lille 2, Institut Pasteur de Lille, Lille, France

Michel Thiry

Affiliation Eurogentec, Parc Scientifique, Seraing, Belgium

Joseph Martial

Affiliation Eurogentec, Parc Scientifique, Seraing, Belgium

Christian Libersa

Affiliations Inserm CIC-CRB 9301, CHRU, Lille, France, Université Lille – Nord de France, Département de Pharmacologie Médicale, Faculté de Médecine, Lille, France

André Capron

Affiliation Inserm – Université Lille 2, Institut Pasteur de Lille, Lille, France

Competing Interests

The authors declare that no competing interests exist.

Author Contributions

Conceived and designed the experiments: GR AMS JM CL AC. Performed the experiments: FR AMS MT HV CL. Analyzed the data: GR DD FR AMS HV AC. Contributed reagents/materials/analysis tools: MC MT JM. Wrote the paper: GR DD FR MC AC. Managed the project presentation to ethical committee and to Inserm for funds: GR MC CL.